According to Future Market Insights, the optic atrophy management market is slated to experience a CAGR of 4.9% from 2023 to 2033, anticipated to reach a valuation of US$ 15.63 billion. An existing medical study in gene replacement therapy found a satisfactory safety record but poor medicinal result durability. The findings of the study are encouraging, and …
Category Archives: Healthcare Trends
3D Bioprinting Market is projected to grow at a CAGR of 12.6% from 2023 to 2033
From 2023 to 2033, the 3D bioprinting market is anticipated to expand at a CAGR of 12.6%. As of 2023, the market is valued at $2 billion USD. The market is anticipated to be worth US$ 6.5 billion by 2033. Academic institutes and hospitals use 3D printing technology to develop various models for training purposes. …
Continue reading “3D Bioprinting Market is projected to grow at a CAGR of 12.6% from 2023 to 2033”
PD-1/PD-L1 Inhibitors Market is expected to reach a valuation of US$ 123.3 billion by 2033
By 2023, the market for PD-1/PD-L1 inhibitors is anticipated to be worth US$ 49.5 billion, and by 2033, it is anticipated to be worth US$ 123.3 billion. During the forecast period, the market is anticipated to register a significant CAGR of 9.6%. PD-1/PD-L1 Inhibitors Market: Dynamics The PD-1/PD-L1 Inhibitors market is among the highest growing …
Self-testing Market is anticipated to capture a valuation of US$ 7.89 billion in 2023
In 2023, the self-testing market is expected to reach a valuation of US$7.89 billion, according to the FMI. By 2033, it is anticipated that the market will grow to $13.6 billion USD. For the forecast period, the market is securing a CAGR of 5.6%. Consumers are swiftly adapting to buy self-testing kits due to early …
Physiotherapy Equipment Market is expected to increase at a 6.5% CAGR from 2023 to 2033
[304 Pages Report] From 2023 to 2033, the market for physiotherapy equipment is anticipated to grow at a 6.5% CAGR. In 2023 and 2033, it is projected to generate valuations of $20,367.16 million and $38,134.8 million, respectively. The increasing levels of physical inactivity is leading to various problems such as frozen joints, muscle degeneration, sprains …
Lab Chip Devices Market is likely to grow to a valuation of US$ 13.99 Billion by 2032
It is expected that the global market size of lab chip devices will reach US$ 5.91 billion in 2022. The market is forecasted to grow at a CAGR of 9.00% during the period of 2022 to 2032, with an estimated valuation of US$ 13.99 billion by 2032. The Lab Chip device technology is rapidly driving …
Meningitis Treatment Market is likely to register a CAGR of 4.1% through 2032
Between 2022 and 2032, the market for meningitis treatment is expected to experience a CAGR of 4.1%. The market is projected to be valued at US$ 146.6 million in 2022 and is forecasted to surpass a worth of US$ 219.10 million by 2032. The increasing prevalence of meningitis, particularly its chronic form, among the elderly …
Continue reading “Meningitis Treatment Market is likely to register a CAGR of 4.1% through 2032”
Non-Alcoholic Steatohepatitis Clinical Trials Market is projected to reach US$ 5.1 billion by 2032
Future Market Insights research on the Non-Alcoholic Steatohepatitis Clinical Trials Market indicates that global sales remained stable at US$ 2.5 billion in 2021. However, the market is expected to grow significantly from 2022 to 2032, with a projected growth rate of 7%, which is higher than the historical increase. Phase 3 is anticipated to be …
Tendonitis Treatment Market is expected to reach US$ 301.8 billion by 2032
According to a recent market analysis report by Future Market Insights, the global Tendonitis Treatment Market generated sales of US$ 193.7 billion in 2021. The report forecasts a substantial increase in market growth from 2022 to 2032, with a projected Compound Annual Growth Rate (CAGR) of 4.1%, significantly higher than the historical rate. The Tendonitis …
Continue reading “Tendonitis Treatment Market is expected to reach US$ 301.8 billion by 2032”
Prostate Cancer Market to reach US$ 24.7 Billion by 2033; Chemotherapy to account for 12% of all Treatment Options
Future Market Insights predicts that the global prostate cancer market will expand rapidly between 2023 and 2033. It is estimated that worldwide sales of prostate cancer medications are expected to reach nearly US$ 24.7 Billion by 2033. Recent developments in drug development, an increasing number of drugs that have been approved by the FDA, and …